Cancers of the Head and Neck Unknown Status Phase 2 Trials for Imatinib (DB00619)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00180921Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and NeckTreatment